Outset Medical, Inc.
OM
$4.56
$0.122.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.43M | 31.42M | 29.75M | 29.47M | 28.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.43M | 31.42M | 29.75M | 29.47M | 28.67M |
| Cost of Revenue | 17.84M | 19.55M | 18.69M | 18.14M | 18.85M |
| Gross Profit | 11.59M | 11.87M | 11.07M | 11.33M | 9.82M |
| SG&A Expenses | 22.03M | 23.44M | 21.99M | 21.85M | 25.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.24M | 48.28M | 46.16M | 45.77M | 52.51M |
| Operating Income | -15.81M | -16.87M | -16.41M | -16.31M | -23.84M |
| Income Before Tax | -17.43M | -18.44M | -25.67M | -25.64M | -27.76M |
| Income Tax Expenses | 404.00K | 104.00K | 115.00K | -4.00K | 182.00K |
| Earnings from Continuing Operations | -17.84M | -18.54M | -25.78M | -25.64M | -27.94M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.84M | -18.54M | -25.78M | -25.64M | -27.94M |
| EBIT | -15.81M | -16.87M | -16.41M | -16.31M | -23.84M |
| EBITDA | -14.80M | -15.71M | -15.11M | -14.90M | -22.45M |
| EPS Basic | -1.00 | -1.05 | -3.66 | -7.29 | -8.02 |
| Normalized Basic EPS | -0.61 | -0.65 | -1.60 | -3.57 | -4.98 |
| EPS Diluted | -1.00 | -1.05 | -3.66 | -7.29 | -8.02 |
| Normalized Diluted EPS | -0.61 | -0.65 | -1.60 | -3.57 | -4.98 |
| Average Basic Shares Outstanding | 17.78M | 17.74M | 7.04M | 3.52M | 3.48M |
| Average Diluted Shares Outstanding | 17.78M | 17.74M | 7.04M | 3.52M | 3.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |